Long term effects of aromatase inhibitor treatment in patients with aromatase excess syndrome
IntroductionAromatase excess syndrome (AEXS) is a rare, autosomal dominant disorder, characterized by enhanced aromatization of androgens and estrogen excess. In males it is characterized by pre-/peripubertal gynecomastia, hypogonadotropic hypogonadism, advanced bone age and short adult height. Only...
Saved in:
Main Authors: | Eleni Z. Giannopoulou, Stephanie Brandt, Stefanie Zorn, Christian Denzer, Julia von Schnurbein, Maki Fukami, Alexander Kaiser, Martin Schmidt, Martin Wabitsch |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1487884/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficient sex hormone biosensors in Saccharomyces cerevisiae cells to evaluate human aromatase activity and inhibition
by: Jie Wu, et al.
Published: (2025-01-01) -
Aromatase inhibitors can improve the semen quality of aged roosters by up regulating genes related to steroid hormone synthesis
by: Xuliang Luo, et al.
Published: (2024-12-01) -
Association between the aromatase (CYP19A1) gene variant rs10046 and cardiovascular risk in postmenopausal women
by: Betânia Rodrigues dos Santos, et al.
Published: (2025-01-01) -
Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors
by: Mohamed A. Kotb, et al.
Published: (2024-11-01) -
Computational studies and structural insights for discovery of potential natural aromatase modulators for hormone-dependent breast cancer
by: Snehal Aditya Arvindekar, et al.
Published: (2024-09-01)